Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers

[1]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[2]  G. Lou,et al.  Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients. , 2018, Gynecologic oncology.

[3]  J. Joo,et al.  Treatment Results and Prognostic Factors of Brain Metastases From Ovarian Cancer: A Single Institutional Experience of 56 Patients , 2018, International Journal of Gynecologic Cancer.

[4]  N. Popitsch,et al.  Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations , 2017, Journal of Neuro-Oncology.

[5]  A. Sapino,et al.  Androgen receptor status predicts development of brain metastases in ovarian cancers , 2017, Oncotarget.

[6]  N. Biglia,et al.  Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19). , 2016, Gynecologic oncology.

[7]  C. Sotiriou,et al.  The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data , 2016, Clinical Cancer Research.

[8]  Luzhe Sun,et al.  The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications , 2016, Oncotarget.

[9]  Kai Xu,et al.  Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis , 2016, Oncotarget.

[10]  P. Martin-Hirsch,et al.  Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival , 2016, British Journal of Cancer.

[11]  M. Trippel,et al.  Androgen receptor status is highly conserved during tumor progression of breast cancer , 2015, BMC Cancer.

[12]  H. Hollema,et al.  Hormone receptors as a marker of poor survival in epithelial ovarian cancer. , 2015, Gynecologic oncology.

[13]  Stephen T. C. Wong,et al.  Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. , 2015, American journal of physiology. Cell physiology.

[14]  J. Karamchandani,et al.  Metastatic ovarian carcinoma to the brain: An approach to identification and classification for neuropathologists , 2015, Neuropathology : official journal of the Japanese Society of Neuropathology.

[15]  Hong Cheng,et al.  Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer , 2014, BMC Cancer.

[16]  Lukyanova Ny,et al.  Clinical significance of hormonal receptor status of malignant ovarian tumors. , 2014, Experimental oncology.

[17]  B. Jabbari,et al.  Brain metastasis from ovarian cancer: a systematic review , 2014, Journal of Neuro-Oncology.

[18]  Yiling Lu,et al.  Predicting time to ovarian carcinoma recurrence using protein markers. , 2013, The Journal of clinical investigation.

[19]  Tomoyoshi Soga,et al.  Oncometabolites: linking altered metabolism with cancer. , 2013, The Journal of clinical investigation.

[20]  H. Koizumi,et al.  Proteomic analysis of differential protein expression by brain metastases of gynecological malignancies , 2013, Human Cell.

[21]  M. Muckenthaler,et al.  Novel mutations in the ferritin-L iron-responsive element that only mildly impair IRP binding cause hereditary hyperferritinaemia cataract syndrome , 2013, Orphanet Journal of Rare Diseases.

[22]  M. Shimada,et al.  Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial). , 2013, Gynecologic oncology.

[23]  K. Yoshihara,et al.  Increased incidence of brain metastases in BRCA1‐related ovarian cancers , 2013, The journal of obstetrics and gynaecology research.

[24]  Chih-Long Chang,et al.  Brain metastases from epithelial ovarian carcinoma: evaluation of prognosis and managements - a Taiwanese Gynecologic Oncology Group (TGOG) study. , 2012, Gynecologic oncology.

[25]  B. Piura,et al.  Brain Metastases from Ovarian Carcinoma , 2011, ISRN oncology.

[26]  A. Sood,et al.  Multidrug Resistance Gene (MDR-1) and Risk of Brain Metastasis in Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer , 2011, American journal of clinical oncology.

[27]  L. Selvaggi,et al.  Central Nervous System Metastases From Epithelial Ovarian Cancer: Prognostic Factors and Outcomes , 2011, International Journal of Gynecologic Cancer.

[28]  J. Smyth,et al.  Higher Incidence of Isolated Brain Metastases in Ovarian Cancer Patients With Previous Early Breast Cancer , 2010, International Journal of Gynecologic Cancer.

[29]  J. Brändstedt,et al.  Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival , 2010, Journal of ovarian research.

[30]  G. Viale,et al.  Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers , 2010, Breast Cancer Research and Treatment.

[31]  A. Reuss,et al.  Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials , 2009, Cancer.

[32]  D. Boehmer,et al.  Brain metastases in relapsed epithelial ovarian cancer after chemotherapy with pegylated liposomal doxorubicin. , 2008, Anticancer research.

[33]  C. Fisher,et al.  Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  P. Sabbatini,et al.  Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[35]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..